Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

  • MDS Inc.

Mar 2007
MDS Inc. of Toronto will acquire Molecular Devices Corp. of Sunnyvale, Calif., a manufacturer of cellular analysis and biochemical testing products for drug discovery and other life sciences applications. The deal is worth $615 million in cash, including $585 million for the purchase of outstanding shares and $30 million for outstanding stock options. The Canadian company intends to combine Molecular Devices and MDS Sciex to create a business unit with more than 1100 employees. Molecular Devices’ cellular analysis and biochemical screening products will retain their brand names, and MDS Sciex will continue to expand its mass spectrometry franchise.

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!